Zhang Ni, Liu Qingbin, Wang Qian, Liu Xiuli, Zhang Suya, Tian Xinchen, Li Long, Wang Shuanglong, Lv Bin, Jiang Shulong
Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250000, P.R. China.
Clinical Medical Laboratory Center, Jining First People's Hospital, Shandong First Medical University, Jining, Shandong 272000, P.R. China.
Oncol Lett. 2025 Jan 7;29(3):130. doi: 10.3892/ol.2025.14876. eCollection 2025 Mar.
Papillary thyroid cancer (PTC) is frequently associated with inflammation and lymph node metastasis. Single-cell RNA sequencing (scRNA-seq) is a powerful tool to uncover rare cellular subpopulations and investigate the diverse functions inside tissue microenvironments. In the present study, scRNA-seq analysis was employed to analyze the differences in macrophages, dendritic cells (DCs) and T cells between a metastatic PTC (PTC-M) and its adjacent normal tissues, as well as a PTC tumor without metastasis. The findings revealed significant heterogeneity in immune cell populations in PTC-M, suggesting that immunosuppressive components contribute to the development and metastasis of PTC. The current study revealed that the presence of alternatively activated M2 macrophages, conventional type 2 DCs (DC2s) and regulatory T cells (Tregs) was associated with increased lymph node metastasis and a more advanced stage of cancer. On the other hand, monocytes and B cells may have a beneficial effect in fighting against tumors. A group of tumor-associated DC2s expressing both and were shown to have a variety of immune-related ligands. These cells have the ability to attract CD4+ T cells through communication between cells in the microenvironment. In this study, the immunological composition was examined at the level of individual cells and new prospective treatment approaches for PTC-M were identified. The results support the hypothesis that myeloid cells and Tregs significantly contribute to tumor progression and metastasis by shaping the tumor microenvironment.
甲状腺乳头状癌(PTC)常与炎症和淋巴结转移相关。单细胞RNA测序(scRNA-seq)是一种强大的工具,可用于揭示罕见的细胞亚群并研究组织微环境中的多种功能。在本研究中,采用scRNA-seq分析来分析转移性PTC(PTC-M)与其相邻正常组织以及无转移的PTC肿瘤之间巨噬细胞、树突状细胞(DC)和T细胞的差异。研究结果显示PTC-M中免疫细胞群体存在显著异质性,表明免疫抑制成分促进了PTC的发生和转移。当前研究表明,交替激活的M2巨噬细胞、传统2型DC(DC2)和调节性T细胞(Treg)的存在与淋巴结转移增加和癌症分期更晚有关。另一方面,单核细胞和B细胞可能对抵抗肿瘤具有有益作用。一组同时表达 和 的肿瘤相关DC2显示具有多种免疫相关配体。这些细胞能够通过微环境中的细胞间通讯吸引CD4+ T细胞。在本研究中,在单个细胞水平上检查了免疫组成,并确定了PTC-M的新的前瞻性治疗方法。结果支持以下假设,即髓样细胞和Treg通过塑造肿瘤微环境显著促进肿瘤进展和转移。
Front Endocrinol (Lausanne). 2020
Lancet Diabetes Endocrinol. 2022-4
Nat Rev Clin Oncol. 2022-4
Front Endocrinol (Lausanne). 2021